[go: up one dir, main page]

PL173147B1 - Novel derivative of pyrimidobenzodiazepin - Google Patents

Novel derivative of pyrimidobenzodiazepin

Info

Publication number
PL173147B1
PL173147B1 PL94302380A PL30238094A PL173147B1 PL 173147 B1 PL173147 B1 PL 173147B1 PL 94302380 A PL94302380 A PL 94302380A PL 30238094 A PL30238094 A PL 30238094A PL 173147 B1 PL173147 B1 PL 173147B1
Authority
PL
Poland
Prior art keywords
pyrimidobenzodiazepin
oxo
derivative
novel derivative
methyl
Prior art date
Application number
PL94302380A
Other languages
Polish (pl)
Other versions
PL302380A1 (en
Inventor
Anna Długosz
Original Assignee
Akad Medyczna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akad Medyczna filed Critical Akad Medyczna
Priority to PL94302380A priority Critical patent/PL173147B1/en
Publication of PL302380A1 publication Critical patent/PL302380A1/en
Publication of PL173147B1 publication Critical patent/PL173147B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Nowa pochodna pirymidobenzodiazepiny o nazwie 2-[di/2-hydroksyetylo/amino']-4-metylo-5-okso-6,11-dihydropirymido [4,5-b] [L5]benzodi;zepma .i wzorze przedstawionym na rysunku.A new derivative of pyrimidobenzodiazepine called 2-[di/2-hydroxyethyl/amino']-4-methyl-5-oxo-6,11-dihydropyrimido [4,5-b] [L5]benzodiazepine with the formula shown in the figure.

Description

Przedmiotem wynalazku jest nowa pochodna pirymidobenzodiazepiny o nazwie 2-[di/2hydroksyetylo/amino]-4-metylo-5-okso-6,11-dihydropirymieo -44^,5-b ] 11,5] bez/Odzeepina, o wzorze przedstawionym na rysunku, wykazująca aktywność immunosupresyjną.The subject of the invention is a new pyrimidobenzodiazepine derivative named 2- [di (2-hydroxyethyl) amino] -4-methyl-5-oxo-6,11-dihydropyrimie-44-, 5-b] 11.5] without (Odzeepin), with the formula in the figure, showing immunosuppressive activity.

Wynalazek dotyczy nowej pochodnej pirymidobenzodiazepiny o nazwie 2-[di/2-hydroksyeSylo/anυeo]-4-mct.ylo-5-okso-6,1.l5dlhyeropirymieo-[4,5-b] [1,5] benzodrnepinai wzorze przedstawionym na rysunku.The invention relates to a novel pyrimidobenzodiazepine derivative named 2- [di (2-hydroxyeSyl / anυeo] -4-mct.yl-5-oxo-6,1.15dlhyeropyrimie- [4,5-b] [1,5] benzodrnepinine, with the formula shown in in the drawing.

Nową pochodną pirymieobbnzoeiazbpiny wytwarza się przez ogrzewanie 2-chloro-4-metylo-5-okso-6,11-dihydropirymido [4,5-b] [1,5] benzodiazepiny z eietaeoloaminą w butanolu wobec Srietyloamiey.The new pyrimieobnzoiazbpin derivative is prepared by heating 2-chloro-4-methyl-5-oxo-6,11-dihydropyrimido [4,5-b] [1,5] benzodiazepine with eietaeolamine in butanol against Srietylamiey.

Nowa pochodna pirymieobeezoeiazepiey zgodna z wynalazkiem, w teście na reakcję nadwrażliwości typu opóźnionego /DTH/ u myszy uczulonych SRBC działa około dwukrotnie silniej od cyklosporyny A. W testach określających liczbę komórek PFC, produkujących swoiste przeciwciała klasy IgM przez komórki śledziony w obecności SRBC, związek działa silniej od cyklosporyny A in vitro, a słabiej in vivo.The new derivative of the pyrimienesoeiazepiene according to the invention, in the delayed-type hypersensitivity reaction (DTH) test in SRBC-sensitized mice, is about twice as strong as cyclosporin A. In tests to determine the number of PFC cells, producing specific IgM antibodies by spleen cells in the presence of SRBC, the compound works more potently than cyclosporin A in vitro and less in vivo.

Przedmiot wynalazku wytwarza się według niżej podanego przykładowego sposobu.The subject of the invention is produced according to the following exemplary method.

Przykład. Do 1,3 g /0,005 m/ 25ehloro545metylo55-okso-6,11-dihydropirymieo [4,5-b] [ 1,5] Βί-'π/ούίαζερίη)' w 350 mi butieiolu (^(^t^ijje się 0,5 g /0,005 m/ diet£eloioίmliny rozpuszczonea w 5 ml butanolu, wkrapla 1 ml trieSyloamiey i całość ogrzewa przez czas 10 godzin we wrzeniu. Roztwór przesącza się na gorąco i zagęszcza do 1/3 objętości. Odsącza się 0,9 g produktu, który krystalizuje się dwukrotnie z metanolu, co stanowi 44% wydajności teoretycznej. Otrzymana 25[ei/2-hydroksyeSylo/amm(i]-4-metylo-5-okso-6,l 1 -dihydropirymido - [4,5-b] [1,5] benzoeiiazepina jest białą drobeokrystaliczeą substancją w postaci igieł, o temperaturze topnienia 167 169°C.Example. Up to 1.3 g / 0.005 m / 25ehloro545metylo55-oxo-6,11-dihydropyrimieo [4,5-b] [1,5] Βί-'π / ούίαζερίη) 'in 350 ml of butieiol (^ (^ t ^ and 0.5 g / 0.005 m / of diet of eloioίmlin dissolved in 5 ml of butanol, 1 ml of trieSyloamiea is added dropwise and the whole is heated for 10 hours under reflux. The solution is filtered hot and concentrated to 1/3 volume. 0.9 g is filtered off. of the product which is crystallized twice from methanol, which is 44% of theory. 25 [[mu] l (2-hydroxyeSyl) amm (i] -4-methyl-5-oxo-6.11-dihydropyrimido - [4,5- b] [1,5] benzoeiiazepine is a white, needle-crystalline substance in the form of needles, melting point 167 169 ° C.

HbC 0 HHbC 0H

Departament Wydawnictw UP RP. Nakład 90 egz. Cena 2,00 złPublishing Department of the UP RP. Circulation of 90 copies. Price PLN 2.00

Claims (1)

Zastrzeżenie patentowePatent claim Nowa pochodna pirymidobenzodiazepiny o nazwie 2-[di/2-hydroksyetylo/amino]-4-metylo-5-oks()-6J1-dihydropiryrnido [4,5-b] [1,5] benzodiazepina i wzorze preedstawionym na rysunku.A new pyrimidobenzodiazepine derivative named 2- [di (2-hydroxyethyl) amino] -4-methyl-5-ox () - 6J1-dihydropyrrinido [4,5-b] [1,5] benzodiazepine and the formula shown in the figure.
PL94302380A 1994-02-23 1994-02-23 Novel derivative of pyrimidobenzodiazepin PL173147B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL94302380A PL173147B1 (en) 1994-02-23 1994-02-23 Novel derivative of pyrimidobenzodiazepin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL94302380A PL173147B1 (en) 1994-02-23 1994-02-23 Novel derivative of pyrimidobenzodiazepin

Publications (2)

Publication Number Publication Date
PL302380A1 PL302380A1 (en) 1995-09-04
PL173147B1 true PL173147B1 (en) 1998-01-30

Family

ID=20061863

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94302380A PL173147B1 (en) 1994-02-23 1994-02-23 Novel derivative of pyrimidobenzodiazepin

Country Status (1)

Country Link
PL (1) PL173147B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8470812B2 (en) 2009-12-30 2013-06-25 Arqule, Inc. Substituted benzo-pyrimido-tetrazolo-diazepine compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8470812B2 (en) 2009-12-30 2013-06-25 Arqule, Inc. Substituted benzo-pyrimido-tetrazolo-diazepine compounds

Also Published As

Publication number Publication date
PL302380A1 (en) 1995-09-04

Similar Documents

Publication Publication Date Title
ATE87006T1 (en) PEPTIDE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE.
Feldman et al. Trigonal-bipyramidal and square-pyramidal tungstacyclobutane intermediates are both present in systems in which olefins are metathesized by complexes of the type W (CHR')(N-2, 6-C6H3-iso-Pr2)(OR) 2
Jacobson et al. Molecular probes for extracellular adenosine receptors
PT76584B (en) NEW INTERMEDIATE PRODUCTS PROCESS FOR THEIR PREPARATION AND ITS USE
TR199902213T2 (en) Pyrazol t�revleri haz�rlanmas� i�in bir proses.
EP0506748B1 (en) Amino acids, peptides or derivatives thereof coupled to fats
DE69823662D1 (en) 1,4,7,10-TETRAAZABICYCLO (8.2.2) TETRADECAN-2-ON, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR THE PRODUCTION OF TETRAAZAMACROCYCLEN
EP0759032A4 (en) ISOLATED PEPTIDES, DERIVATIVES OF MAGE-3, PRODUCING A COMPLEX WITH HLA-A2 MOLECULES, AND APPLICATIONS
DE3564681D1 (en) Process for the preparation of (2-hydroxyethyl)melamines
AR006058A1 (en) PROCEDURES FOR PREPARING DICIANOACETATE AND 1,2-PYRAZOLE-5-AMINO-3-SUBSTITUTED COMPOUNDS
Glick Membrane glycopeptides from virus-transformed hamster fibroblasts and the normal counterpart
Hsu et al. Growth control in cultured 3T3 fibroblasts: neutralization and identification of a growth-inhibitory factor by a monoclonal antibody.
PL173147B1 (en) Novel derivative of pyrimidobenzodiazepin
Ruoslahti et al. Alpha-fetoproteins produced by the yolk sac and the liver are glycosylated differently
Horiuchi et al. Evidence against in vivo presence of 2-(2-furoyl)-4 (5)-(2-furanyl)-1H-imidazole, a major fluorescent advanced end product generated by nonenzymatic glycosylation.
DE3025226C2 (en) Pterin derivatives and their use for the radioimmunological determination of pterins
ATE160288T1 (en) ANTIBODIES, THEIR PRODUCTION AND USE
Latli et al. [3H] Imidacloprid: synthesis of a candidate radioligand for the nicotinic acetylcholine receptor
EP0442372B1 (en) Improved labeled haptens, process for their preparation and the use of these labeled haptens in immunoassays
WO1995020764A1 (en) Specific binding substances for antibodies and their use for immunoassays or vaccines
TW327612B (en) Process for the preparation of a mixed oxide and process for the ammoxidation of alkanes using the mixed oxide prepared therefrom
EP0882767A4 (en) Bisazo compounds and process for the preparation thereof
Horvat et al. Synthesis of hexose-related imidazolidinones: Novel glycation products in the Maillard reaction
EA200000924A3 (en) Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
EP1013642A2 (en) Chelating agents and the technetium and rhenium tricarbonyl complexes thereof